The Influence of miRNAs on Radiotherapy Treatment in Prostate Cancer - A Systematic Review

In the last years, extensive investigation on miRNomics have shown to have great advantages in cancer personalized medicine regarding diagnosis, treatment and even clinical outcomes. Prostate cancer (PCa) is the second most common male cancer and about 50% of all PCa patients received radiotherapy (...

ver descrição completa

Detalhes bibliográficos
Autor principal: Soares, Sílvia (author)
Outros Autores: Guerreiro, Susana G (author), Cruz-Martins, Natália (author), Faria, Isabel (author), Baylina, Pilar (author), Sales, Maria Goreti (author), Correa-Duarte, Miguel A (author), Fernandes, Rúben (author)
Formato: article
Idioma:eng
Publicado em: 2021
Assuntos:
RNA therapy; microRNA; oncomiR; oncosupressor miR; prostate cancer; radiotherapy
Texto completo:http://hdl.handle.net/10316/95713
País:Portugal
Oai:oai:estudogeral.sib.uc.pt:10316/95713

Texto Completo

http://hdl.handle.net/10316/95713

Registros relacionados